No plans to enter vaccine production as it needs different manufacturing infra: Dilip Sanghvi
The company is eyeing biosimilars to fuel its future growth
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
business plans
Post-COVID, there will be a mix of various working models
Koki Sato, Country Head and GM, Takeda India talks about the company’s recent drug launch in India, its plans for the Indian…
Aim to gain market share, preserve cash, reduce overall debt in times of COVID-19: Dilip Shanghvi
The company's focus is also on supply chain protection and ensuring optimum utilisation of its factories informed the MD of the…
There will be a positive impact of the coronavirus on our balance sheet
The nationwide lockdown due to the COVID-19 pandemic has impacted business operations across sectors. However, the Sami-Sabinsa …